{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T12:21:19Z","timestamp":1792758079026,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007268","name":"Washington University in St. Louis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Preventive Medicine"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.ypmed.2021.106729","type":"journal-article","created":{"date-parts":[[2021,7,20]],"date-time":"2021-07-20T01:19:58Z","timestamp":1626743998000},"page":"106729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"special_numbering":"P2","title":["Polysubstance use trends and variability among individuals with opioid use disorder in rural versus urban settings"],"prefix":"10.1016","volume":"152","author":[{"given":"Matthew S.","family":"Ellis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary A.","family":"Kasper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore J.","family":"Cicero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ypmed.2021.106729_bb0005","series-title":"Categorical Data Analysis","author":"Agresti","year":"2013"},{"key":"10.1016\/j.ypmed.2021.106729_bb0010","doi-asserted-by":"crossref","first-page":"108307","DOI":"10.1016\/j.drugalcdep.2020.108307","article-title":"Contingency management for the treatment of methamphetamine use disorder: a systematic review","volume":"216","author":"Brown","year":"2020","journal-title":"Drug Alcohol Depend."},{"issue":"3","key":"10.1016\/j.ypmed.2021.106729_bb0015","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.drugalcdep.2012.11.018","article-title":"National trends in pharmaceutical opioid related overdose deaths compared to other substance related overdose deaths: 1999\u20132009","volume":"131","author":"Calcaterra","year":"2013","journal-title":"Drug Alcohol Depend."},{"key":"10.1016\/j.ypmed.2021.106729_bb0020","author":"Centers for Disease Control and Prevention"},{"issue":"3","key":"10.1016\/j.ypmed.2021.106729_bb0025","doi-asserted-by":"crossref","first-page":"259","DOI":"10.31887\/DCNS.2017.19.3\/tcicero","article-title":"The prescription opioid epidemic: a review of qualitative studies on the progression from initial use to abuse","volume":"19","author":"Cicero","year":"2017","journal-title":"Dialogues Clin. Neurosci."},{"key":"10.1016\/j.ypmed.2021.106729_bb0030","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.addbeh.2018.05.015","article-title":"Oral and non-oral routes of administration among prescription opioid users: pathways, decision-making and directionality","volume":"86","author":"Cicero","year":"2018","journal-title":"Addict. Behav."},{"issue":"2","key":"10.1016\/j.ypmed.2021.106729_bb0035","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/002204261104100207","article-title":"Multiple determinants of specific modes of prescription opioid diversion","volume":"41","author":"Cicero","year":"2011","journal-title":"J. Drug Issues"},{"issue":"7","key":"10.1016\/j.ypmed.2021.106729_bb0040","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1001\/jamapsychiatry.2014.366","article-title":"The changing face of heroin use in the United States: a retrospective analysis of the past 50 years","volume":"71","author":"Cicero","year":"2014","journal-title":"JAMA Psychiatry."},{"issue":"2","key":"10.1016\/j.ypmed.2021.106729_bb0045","doi-asserted-by":"crossref","first-page":"244","DOI":"10.2105\/AJPH.2019.305412","article-title":"Polysubstance use: a broader understanding of substance use during the opioid crisis","volume":"110","author":"Cicero","year":"2020","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ypmed.2021.106729_bb0050","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41380-020-00949-3","article-title":"Polysubstance use in the U.S. opioid crisis","volume":"26","author":"Compton","year":"2021","journal-title":"Mol. Psychiatry"},{"issue":"5","key":"10.1016\/j.ypmed.2021.106729_bb0055","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.drugpo.2012.01.012","article-title":"\u201cI'm not afraid of those ones just 'cause they've been prescribed\u201d: perceptions of risk among illicit users of pharmaceutical opioids","volume":"23","author":"Daniulaityte","year":"2012","journal-title":"Int. J. Drug. Policy."},{"issue":"3","key":"10.1016\/j.ypmed.2021.106729_bb0060","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1056\/NEJMsa1406143","article-title":"Trends in opioid analgesic abuse and mortality in the United States","volume":"372","author":"Dart","year":"2015","journal-title":"N. Engl. J. Med."},{"issue":"2","key":"10.1016\/j.ypmed.2021.106729_bb0065","doi-asserted-by":"crossref","first-page":"182","DOI":"10.2105\/AJPH.2017.304187","article-title":"Opioid crisis: no easy fix to its social and economic determinants","volume":"108","author":"Dasgupta","year":"2018","journal-title":"Am. J. Public Health"},{"key":"10.1016\/j.ypmed.2021.106729_bb0070","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.drugalcdep.2018.08.029","article-title":"Twin epidemics: the surging rise of methamphetamine use in chronic opioid users","volume":"193","author":"Ellis","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"34","key":"10.1016\/j.ypmed.2021.106729_bb0075","doi-asserted-by":"crossref","first-page":"737","DOI":"10.15585\/mmwr.mm6834a2","article-title":"Changes in opioid-involved overdose deaths by opioid type and presence of benzodiazepines, cocaine, and methamphetamine - 25 states, July-December 2017 to January-June 2018","volume":"68","author":"Gladden","year":"2019","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2021.106729_bb0080","doi-asserted-by":"crossref","first-page":"697","DOI":"10.15585\/mmwr.mm6626a4","article-title":"Vital signs: changes in opioid prescribing in the United States, 2006\u20132015","volume":"66","author":"Guy","year":"2017","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"issue":"1","key":"10.1016\/j.ypmed.2021.106729_bb0085","doi-asserted-by":"crossref","DOI":"10.5210\/ojphi.v9i1.7733","article-title":"Using local toxicology data for drug overdose mortality surveillance","volume":"9","author":"Hannah","year":"2017","journal-title":"Online J. Public Health Inform."},{"key":"10.1016\/j.ypmed.2021.106729_bb0090","first-page":"1","article-title":"Increase in drug overdose deaths involving cocaine: United States, 2009\u20132018","volume":"384","author":"Hedegaard","year":"2020","journal-title":"NCHS Data Brief."},{"issue":"1","key":"10.1016\/j.ypmed.2021.106729_bb0095","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/jrh.12442","article-title":"COVID-19 during the opioid epidemic - exacerbation of stigma and vulnerabilities","volume":"37","author":"Jenkins","year":"2021","journal-title":"J. Rural. Health"},{"issue":"2","key":"10.1016\/j.ypmed.2021.106729_bb0100","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/add.14812","article-title":"Increases in methamphetamine use among heroin treatment admissions in the United States, 2008-17","volume":"115","author":"Jones","year":"2020","journal-title":"Addiction."},{"issue":"2","key":"10.1016\/j.ypmed.2021.106729_bb0105","doi-asserted-by":"crossref","DOI":"10.2105\/AJPH.2013.301709","article-title":"Understanding the rural-urban differences in nonmedical prescription opioid use and abuse in the United States","volume":"104","author":"Keyes","year":"2014","journal-title":"Am. J. Public Health"},{"issue":"4","key":"10.1016\/j.ypmed.2021.106729_bb0110","doi-asserted-by":"crossref","DOI":"10.1097\/ADM.0000000000000684","article-title":"Opioid use disorder and COVID-19: crashing of the crises","volume":"14","author":"Khatri","year":"2020","journal-title":"J. Addict. Med."},{"key":"10.1016\/j.ypmed.2021.106729_bb0115","author":"Linzer"},{"key":"10.1016\/j.ypmed.2021.106729_bb0120","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.15585\/mmwr.mm6934a1","article-title":"Nonfatal drug and polydrug overdoses treated in emergency departments \u2014 29 states, 2018\u20132019","volume":"69","author":"Liu","year":"2020","journal-title":"MMWR Morb. Mortal. Wkly Rep."},{"key":"10.1016\/j.ypmed.2021.106729_bb0125","doi-asserted-by":"crossref","first-page":"106752","DOI":"10.1016\/j.addbeh.2020.106752","article-title":"High prevalence of co-occurring substance use in individuals with opioid use disorder","volume":"114","author":"Mahoney","year":"2021","journal-title":"Addict. Behav."},{"issue":"7","key":"10.1016\/j.ypmed.2021.106729_bb0130","doi-asserted-by":"crossref","first-page":"504","DOI":"10.7326\/M19-2403","article-title":"Growth and distribution of buprenorphine-waivered providers in the United States, 2007-2017","volume":"172","author":"McBain","year":"2020","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ypmed.2021.106729_bb0135","series-title":"Comparing prescription opioids, methadone, and heroin rates from the Treatment Episode Data Set to the RADARS\u00ae System Treatment Center Programs Combined. RADARS\u00ae System Technical Report, 2016-Q2","author":"McDaniel","year":"2016"},{"key":"10.1016\/j.ypmed.2021.106729_bb0140","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jrurstud.2018.12.004","article-title":"The contributions of socioeconomic and opioid supply factors to U.S. drug mortality rates: urban-rural and within-rural differences","volume":"68","author":"Monnat","year":"2019","journal-title":"J. Rural. Stud."},{"issue":"12","key":"10.1016\/j.ypmed.2021.106729_bb0145","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.16520","article-title":"Comparison of rural vs urban direct-to-physician commercial promotion of medications for treating opioid use disorder","volume":"2","author":"Nguyen","year":"2019","journal-title":"JAMA Netw. Open"},{"issue":"1","key":"10.1016\/j.ypmed.2021.106729_bb0150","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s11524-018-00343-z","article-title":"Increased presence of fentanyl in cocaine-involved fatal overdoses: implications for prevention","volume":"96","author":"Nolan","year":"2019","journal-title":"J. Urban Health"},{"issue":"5","key":"10.1016\/j.ypmed.2021.106729_bb0155","article-title":"Retention of patients in opioid substitution treatment: a systematic review","volume":"15","author":"O'Connor","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ypmed.2021.106729_bb0160","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.drugalcdep.2018.05.001","article-title":"Not just heroin: extensive polysubstance use among US high school seniors who currently use heroin","volume":"188","author":"Palamar","year":"2018","journal-title":"Drug Alcohol Depend."},{"issue":"6","key":"10.1016\/j.ypmed.2021.106729_bb0165","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1080\/10826084.2020.1713818","article-title":"Sources of misused prescription opioids and their association with prescription opioid use disorder in the United States: sex and age differences","volume":"55","author":"Park","year":"2020","journal-title":"Subst. Use Misuse"},{"key":"10.1016\/j.ypmed.2021.106729_bb0170","doi-asserted-by":"crossref","first-page":"3405","DOI":"10.2147\/JPR.S295715","article-title":"The polysubstance overdose-death crisis","volume":"13","author":"Peppin","year":"2020","journal-title":"J. Pain Res."},{"issue":"3","key":"10.1016\/j.ypmed.2021.106729_bb0175","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.mayocp.2018.01.018","article-title":"Beyond supply: how we must tackle the opioid epidemic","volume":"93","author":"Srivastava","year":"2018","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ypmed.2021.106729_bb0180","author":"United Nations Office on Drugs and Crime"},{"issue":"1","key":"10.1016\/j.ypmed.2021.106729_bb0185","doi-asserted-by":"crossref","first-page":"61","DOI":"10.7326\/M20-1212","article-title":"Collision of the COVID-19 and addiction epidemics","volume":"173","author":"Volkow","year":"2020","journal-title":"Ann. Intern. Med."}],"container-title":["Preventive Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174352100298X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009174352100298X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T10:12:16Z","timestamp":1758795136000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009174352100298X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":37,"alternative-id":["S009174352100298X"],"URL":"https:\/\/doi.org\/10.1016\/j.ypmed.2021.106729","relation":{},"ISSN":["0091-7435"],"issn-type":[{"value":"0091-7435","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Polysubstance use trends and variability among individuals with opioid use disorder in rural versus urban settings","name":"articletitle","label":"Article Title"},{"value":"Preventive Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ypmed.2021.106729","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"106729"}}